Abstract
Coronary artery bypass grafting (CABG) is relatively safe procedure with estimated mortality rate ranging 1 % through 5 %. Early and late results of CABG are determined by performance of bypass grafts and progression rate in the native coronary arteries. Although perioperative myocardial infarction (PMI) noted in approximately 2.5 % of CABG patients may be either graft or non-graft-related, the latter one dominates. Predominant reason of graft-related PMI is thrombus formation. In this chapter, mechanisms promoting the development of thrombus in bypass grafts and strategies to prevent it are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014. doi:10.1093/eurheartj/ehu278.
Javaid A, Steinberg DH, Buch AN, et al. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease. Circulation. 2007;116(11 Suppl):I200–6.
Mitra AK, Gangahar DM, Agrawal DK. Cellular, molecular and immunological mechanisms in the pathophysiology of vein graft intimal hyperplasia. Immunol Cell Biol. 2006;84:115–24.
Virani SS, Mendoza CE, Arora H, et al. Clinical significance, angiographic characteristics, and short-term outcomes in 30 patients with early coronary artery graft failure. Neth Heart J. 2009;17:13–7.
Rasmussen C, Thiis JJ, Clemmensen P, et al. Significance and management of early graft failure after coronary artery bypass grafting: feasibility and results of acute angiography and re-re-vascularization. Eur J Cardiothorac Surg. 1997;12:847–52.
Favaloro RG, Effler DB, Groves LK, et al. Combined simultaneous procedures in the surgical treatment of coronary artery disease. Ann Thorac Surg. 1969;8:20–9.
Lamy A, Devereaux PJ, Prabhakaran D, et al.; CORONARY Investigators. Off-pump or on-pump coronary-artery bypass grafting at 30 days. N Engl J Med. 2012;366:1489–97.
Shroyer AL, Grover FL, Hattler B, et al.; Veterans Affairs Randomized On/Off Bypass (ROOBY) Study Group. On-pump versus off-pump coronary-artery bypass surgery. N Engl J Med. 2009;361:1827–37.
Taggart DP, Altman DG, Gray AM, et al; on behalf of the ART Investigators. Effects of on-pump and off-pump surgery in the Arterial Revascularization Trial. Eur J Cardiothoracic Surg. 2015;47:1059–65.
Shroyer AL, Hattler B, Wagner TH, et al.; VA #517 Randomized On/Off Bypass (ROOBY) Study Group. Comparing off-pump and on-pump clinical outcomes and costs for diabetic cardiac surgery patients. Ann Thorac Surg. 2014;98:38–44.
Miśkowiec DL, Walczak A, Jaszewski R, et al. Independent predictors of early mortality after CABG in single centre experience – does the gender matter? Kardiol Pol. 2015;73:109–17.
Nalysnyk L, Fahrbach K, Reynolds MW, et al. Adverse events in coronary artery bypass graft (CABG) trials: a systematic review and analysis. Heart. 2003;89:767–72.
ElBardissi AW, Aranki SF, Sheng S, et al. Trends in isolated coronary artery bypass grafting: an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg. 2012;143:273–81.
Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–44.
Bridgewater B, Neve H, Moat N, et al. Predicting operative risk for coronary artery surgery in the United Kingdom: a comparison of various risk prediction algorithms. Heart. 1998;79:350–5.
Nashef SA, Roques F, Michel P, et al. European system for cardiac operative risk evaluation (EuroSCORE). Eur J Cardiothorac Surg. 1999;16:9–13.
O’Brien SM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1 – coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2–22.
Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg. 2000;69:823–8.
Kouchoukos NT, Ebert PA, Grover FL, et al. Report of the ad hoc committee on risk factors for coronary artery bypass surgery. Ann Thorac Surg. 1988;45:348–9.
Clark RE. It is time for a national cardiothoracic surgical data base. Ann Thorac Surg. 1989;48:755–6.
Mandegar MH, Marzban M, Lebaschi AH, et al. Gender influence on hospital mortality after coronary artery bypass surgery. Asian Cardiovasc Thorac Ann. 2008;16:231–5.
Vaccarino V, Abramson JL, Veledar E, et al. Sex differences in hospital mortality after coronary artery bypass surgery: evidence for a higher mortality after coronary artery bypass surgery. Circulation. 2002;105:1176–81.
Ahmed WA, Tully PJ, Psych M, et al. Female sex as an independent predictor of morbidity and survival after isolated coronary artery bypass grafting. Ann Thorac Surg. 2011;92:59–67.
Holzmann MJ, Ahnve S, Hammar N, et al. Creatinine clearance and risk of early mortality in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2005;130:746–52.
Cooper WA, O’Brien SM, Thourani VH, et al. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113:1063–70.
Holzmann MJ, Hammar N, Ahnve S, et al. Renal insufficiency and long‐term mortality and incidence of myocardial infarction in patients undergoing coronary artery bypass grafting. Eur Heart J. 2007;28:865–71.
Holzmann MJ, Ahlbäck E, Jeppsson A, et al. Renal dysfunction and long‐term risk of ischemic and hemorrhagic stroke following coronary artery bypass grafting. Int J Cardiol. 2013;168:1137–42.
Al-Ruzzeh S, Nakamura K, Athanasiou T, et al. Does off-pump coronary artery bypass (OPCAB) surgery improve the outcome in high-risk patients?: a comparative study of 1398 high-risk patients. Eur J Cardiothorac Surg. 2003;23:50–5.
Podgoreanu MV, White WD, Morris RW, et al. Inflammatory gene polymorphisms and risk of postoperative myocardial infarction after cardiac surgery. Circulation. 2006;114:I275–81.
Abramov D, Tamariz MG, Sever JY, et al. The influence of gender on the outcome of coronary artery bypass surgery. Ann Thorac Surg. 2000;70:800–5.
Laflamme M, DeMey N, Bouchard D, et al. Management of early postoperative coronary artery bypass graft failure. Interact Cardiovasc Thorac Surg. 2012;14:452–6.
Davierwala PM, Verevkin A, Leontyev S, et al. Impact of expeditious management of perioperative myocardial ischemia in patients undergoing isolated coronary artery bypass surgery. Circulation. 2013;128 Suppl 1:S226–34.
Steuer J, Hörte LG, Lindahl B, Ståhle E. Impact of perioperative myocardial injury on early and long-term outcome after coronary artery bypass grafting. Eur Heart J. 2002;23:1219–27.
Landesberg G, Beattie WS, Mosseri M, et al. Perioperative myocardial infarction. Circulation. 2009;119:2936–44.
Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50:2173–95.
Adams 3rd JE, Sicard GA, Allen BT, et al. Diagnosis of perioperative myocardial infarction with measurement of cardiac troponin I. N Engl J Med. 1994;330:670–4.
Thielmann M, Massoudy P, Schmermund A, et al. Diagnostic discrimination between graft-related and non-graft-related perioperative myocardial infarction with cardiac troponin I after coronary artery bypass surgery. Eur Heart J. 2005;26:2440–7.
Steuer J, Bjerner T, Duvernoy O, et al. Visualisation and quantification of perioperative myocardial infarction after coronary artery bypass surgery with contrast-enhanced magnetic resonance imaging. Eur Heart J. 2004;25:1293–9.
Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–69.
Erbel R, Heusch G. Brief review: coronary microembolization. J Am Coll Cardiol. 2000;36:22–4.
Thielman M, Dorge H, Martin C, et al. Myocardial dysfunction with coronary microembolization: signal transduction through a sequence of nitric oxide, tumor necrosis factor-alpha, and sphingosine. Circ Res. 2002;19:807–13.
Califf RM, Abdelmeguid AE, Kuntz RE, et al. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241–51.
Skyschally A, Haude M, Dorge H, et al. Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary embolization. Circulation. 2004;109:2337–42.
Rosenfeldt FL, He GW, Buxton BF, Angus JA. Pharmacology of coronary artery bypass grafts. Ann Thorac Surg. 1999;67:878–88.
Goldman S, Zadina K, Moritz T, et al. Long-term patency of sapenous vein and left internal mammary artery after coronary artery bypass surgery: results from the Department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.
Mehta D, Izzat MB, Bryan AJ, et al. Towards the prevention of vein graft failure. Int J Cardiol. 1997;62 Suppl 1:S55–63.
Fitzgibbon GM, Kafka HP, Leach AJ, et al. Coronary artery bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–26.
Tsui JC, Dashwood MR. Recent strategies to reduce vein graft occlusion: a need to limit the effect of vascular damage. Eur J Vasc Endovasc Surg. 2002;23:202–8.
Parang P, Arora R. Coronary vein graft disease: pathogenesis and prevention. Can J Cardiol. 2009;25:e57–62.
Canos DA, Mintz GS, Berzingi C, et al. Clinical, angiographic and intravascular ultrasound characteristics of early saphenous vein graft failure. J Am Coll Cardiol. 2004;44:53–6.
Le May MR, Labinaz M, Marquiz JF, et al. Predictors of long-term outcome after stent implantation in a saphenous vein graft. Am J Cardiol. 1999;83:681–8.
Lip GY, Blann AD. Thrombogenesis, atherogenesis and angiogenesis in vascular disease: a new ‘vascular triad’. Ann Med. 2004;36:119–25.
Nowicki M, Buczkowski P, Miskowiak B, et al. Immunocytochemical study on endothelial integrity of saphenous vein grafts harvested by minimally invasive surgery with the use of vascular mayo stripers. A randomized controlled trial. Eur J Vasc Endovasc Surg. 2004;27:244–50.
Rousou LJ, Taylor KB, Lu XG, et al. Saphenous vein conduits harvested by endoscopic technique exhibit structural and functional damage. Ann Thorac Surg. 2009;87:62–70.
Lopes R, Hafley G, Allen KB, et al. Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med. 2009;361:235–44.
McGeachie JK, Meagher S, Prendergast FJ. Vein-to-artery grafts: the long-term development of neo-intimal hyperplasia and its relationship to vasa vasorum and sympathetic innervation. Aust N Z J Surg. 1989;59:59–65.
de Graaf R, Tintu A, Stassen F, Kloppenburg G, Bruggeman C, Rouwet E. N-acetylcysteine prevents neointima formation in experimental venous bypass grafts. Br J Surg. 2009;96:941–50.
Cook JM, Cook CD, Marlar R, et al. Thrombomodulin activity in human saphenous vein grafts prepared for coronary artery bypass. J Vasc Surg. 1991;14:147–51.
Peykar S, Angiolillo DJ, Bass TA, Costa MA. Saphenous vein graft disease. Minerva Cardioangiol. 2004;52:379–90. Viaro F, Carlotti CG Jr, Rodrigues AJ, et al. Endothelium dysfunction caused by acute pressure distension of human saphenous vein used for myocardial revascularization. Rev Bras Cir Cardiovasc. 2007;22:169–75.
Wilbring M, Ebner A, Schoenemann K, et al. Heparinized blood better preserves cellular energy charge and vascular functions of intraoperatively stored saphenous vein grafts in comparison to isotonic sodium-chloride-solution. Clin Hemorheol Microcirc. 2013;55:445–55.
Verrier ED, Boyle Jr EM. Enthelial cell injury in cardiovascular surgery. Ann Thorac Surg. 1996;62:915–22.
Lee MS, David EM, Makkar RR, et al. Molecular and cellular basis of restenosis after percutaneous coronary intervention: the intertwining roles of platelets, leucocytes, and the coagulation-fibrinolysis system. J Pathol. 2004;203:861–70.
Ishiwata S, Tukada T, Nakanishi S, et al. Postangioplasty restenosis: platelet activation and the coagulation-fibrinolysis system as possible factors in the pathogenesis of restenosis. Am Heart J. 1997;133:387–92.
Davies MG, Hagen PO. Pathobiology of intimal hyperplasia. Br J Surg. 1994;81:1254–69.
Thatte HS, Khuri SF. The coronary artery bypass cnduit. I. Intraoperative endothelial injury and its implication on graft patency. Ann Thorac Surg. 2001;72:S2245–52.
Angelini GD, Bryan AJ, Williams HM, et al. Distension promotes latelet and leukocyte adhesion and reduces short-term patency in pig atriovenous bypass graft. J Thorac Cardiovasc Surg. 1990;99:433–9.
Arazi HC, Doiny DG, Torcivia RS, et al. Impaired anti-platelet effect of aspirin, inflammation an platelet turnover in cardiac surgery. Interact Cardiovasc Thorac Surg. 2010;10:863–7.
Daňová K, Pechaň I, Olejárová I, et al. Natriuretic peptides and endothelin-1 in patients undergoing coronary artery bypass grafting. Gen Physiol Biophys. 2007;26:194–9.
Moor E, Hamsten A, Blomback M, et al. Haemostatic factors and inhibitors and coronary bypass grafting: preoperative alterations and relations to graft occlusion. Thromb Haemost. 1994;72:335–42.
Parolari A, Mussoni L, Frigerio M, et al. Increased prothrombotic state lasting as long as one month after on-pump and off-pump coronary surgery. J Thorac Cardiovasc Surg. 2005;130:303–8.
Undar A, Vaughn WK, Calhoon JH. The effects of cardiopulmonary bypass and deep hypothermic circulatory arrest on blood viscoelasticity and cerebral blood flow in a neonatal piglet model. Perfusion. 2000;15:121–8.
Holmvang L, Jurlander B, Rasmussen C, et al. Use of biochemical markers of infarction for diagnosing perioperative myocardial infarction and early graft occlusion after coronary artery bypass surgery. Chest. 2002;121:103–17.
Komori K, Yamamura S, Ishida M, et al. Acceleration of impairment of endothelium-dependent responses under poor runoff conditions in canine autogenous vein grafts. Eur J Vasc Endovasc Surg. 1997;14:475–81.
Rupprecht HJ, Hamm C, Ischinger T, et al. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). GABI Study Group. Eur Heart J. 1996;17:1192–8.
Roth JA, Cukingnan RA, Brown BG, et al. Factors influencing patency of saphenous vein grafts. Ann Thorac Surg. 1979;28:176–83.
Cataldo G, Braga M, Pirotta N, et al. Factors influencing 1-year patency of coronary artery saphenous vein grafts: Studio Indobufene nel Bypass Aortocoronarico (SINBA). Circulation. 1993;88(Suppl II):II-93–8.
Tonino PA, Fearon WF, De Bruyne B, et al. Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation. J Am Coll Cardiol. 2010;55:2816–21.
Dashwood MR, Savage K, Tsui JC, et al. Retaining perivascular tissue of human saphenous vein grafts protects against surgical and distension-induced damage and preserves endothelial nitric oxide synthase and nitrix oxide synthase activity. J Thorac Cardiovasc Surg. 2009;138:334–40.
Stein PD, Dalen JE, Gldman S, et al. Antithrombotic therapy in patients with saphenus vein and internal mammary artery bypass grafts. Chest. 1995;108:424S–30.
Souza DS, Johansson B, Bojo L, et al. Harvesting the saphenous vein with surrounding tissue for CABG provides long-term graft patency comparable to the left internal thoracic artery: results of a randomized longitudinal trial. J Thorac Cardiovasc Surg. 2006;132:373–8.
Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition and prevention. Circulation. 1998;97:916–31.
Verstraete M, Brown BG, Chesebro JH, et al. Evaluation of antiplatelet agents in the prevention of aorto-coronary bypass occlusion. Eur Heart J. 1986;7:4–13.
Goldman S, Copeland J, Moritz T, et al. Improvement in early saphenous vein graft patency after coronary artery bypass surgery with antiplatelet therapy: results of a Veteran Administration Cooperative Study. Circulation. 1988;6:1324–32.
Ratnatunga CP, Edmondson SF, Ree GM, et al. High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation. Circulation. 1992;85:1077–82.
Goldman S, Copeland J, Moritz T, et al. Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study. Circulation. 1989;80:1190–7.
Torsney E, Mayr U, Zou Y, et al. Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ Res. 2004;94:1466–73.
Kim AY, Walinsky PL, Kolodgie FD, et al. Early loss of thrombomodulin expression impairs vein graft thromboresistance: implications for vein graft failure. Circ Res. 2002;90:205–12.
Shukla N, Angelini GD, Wan I, et al. Potential role of nitroaspirin in the treatment of vein graft failure. Ann Thorac Surg. 2003;75:1437–42.
Sparatore A, Perrino E, Tazzari V, et al. Pharmacological profile of a novel H2S-releasing aspirin. Free Radic Biol Med. 2009;46:586–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Perek, B. (2016). Early CABG Failure. In: Ţintoiu, I., Underwood, M., Cook, S., Kitabata, H., Abbas, A. (eds) Coronary Graft Failure. Springer, Cham. https://doi.org/10.1007/978-3-319-26515-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-26515-5_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26513-1
Online ISBN: 978-3-319-26515-5
eBook Packages: MedicineMedicine (R0)